FIELD: medicine. SUBSTANCE: method involves eliminating target cells in cell population having nuclear cells taken from peripheral blood sample or CD-34+ cells or the like early precursor cells. Cell population is exposed in vivo or in vitro to two or more immnunotoxins possessing properties of selective action upon the target cells. EFFECT: enhanced selectivity in acting upon malignant cells. 12 cl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMAGNETIC SEPARATION OF CELLS USED FOR IDENTIFICATION OF GENES ASSOCIATED WITH SITE-PREFERABLE CANCER METASTASIS FORMATION | 1997 |
|
RU2180963C2 |
| ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING HUMAN | 2012 |
|
RU2597831C2 |
| METHOD OF INHIBITING MIGRATION OF CANCER CELLS | 2006 |
|
RU2404805C2 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| CELL ELIMINATION BY USING VIRUSES | 2001 |
|
RU2270685C2 |
| COMPOSITION SHOWING CYTOTOXIC EFFECT, A METHOD OF TREATMENT OF LEUKEMIC CELL IN VITRO | 1993 |
|
RU2127122C1 |
| BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
| METHOD FOR STABLE CELL TRANSDUCTION BY VIRAL VECTORS | 2001 |
|
RU2280074C2 |
| ANTITUMOR TARGET CELL PRODUCT, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2018 |
|
RU2757812C2 |
| CD43 ANTIBODIES AND USE THEREOF FOR TREATING CANCER | 2016 |
|
RU2694903C1 |
